Dren Bio
Developer of a biotechnology platform intended to develop protein-based technologies to deplete pathogenic cells and agents in numerous diseases. The company's platform focuses on hematologic neoplasm...
Valuation
$0
Share Price
N/A
Total Raised
$181.2M
Last Round
N/A